Table 8 Effect of treatment duration on changes in the C18:3n6/C22:4n6 index
From: The C18:3n6/C22:4n6 ratio is a good lipid marker of chronic kidney disease (CKD) progression
Treatment durtion | Average treatment duration [months] | C18:3n6 | C22:4n6 | C18:3n6/C22:4n6 index | Index significance > 10 years |
|---|---|---|---|---|---|
1 year N = 30 | 6.100 | 0.209 | 3.431 | 1.140 ± 1.001 | 0.027717 |
2 years N = 26 | 17.654 | 0.211 | 3.851 | 1.169 ± 1.064 | 0.025942 |
3 years N = 24 | 30.120 | 0.247 | 3.431 | 0.944 ± 0.539 | 0.015754 |
5 years N = 24 | 48.917 | 0.221 | 3.206 | 1.027 ± 0.804 | 0.022576 |
10 years N = 24 | 91.667 | 0.216 | 3.866 | 0.675 ± 0.553 | NS |
> 10 years N = 18 | 199.71 | 0.188 | 3.134 | 0.491 ± 0.305 | – |